The decision in focus
Start with branded access
Ro and Hers list approved products. Compare the precise formulation and prescription quote, then decide whether their care arrangement meets your needs.
Semaglutide shortlist
Compare semaglutide services by branded access, preparation, care fees and refill responsibility.
The decision in focus
Ro and Hers list approved products. Compare the precise formulation and prescription quote, then decide whether their care arrangement meets your needs.
The decision in focus
Mochi’s mixed menu and CoreAge’s compounded semaglutide pathway require a separate product-status discussion. An ingredient name is not a guarantee of equivalence.
“Semaglutide provider” can describe several different purchases. A branded oral product, a branded injection and a compounded preparation should not be collapsed into one cheapest-to-most-expensive list. Ask the clinician to identify the proposed medicine and formulation before collecting matching quotes. Our selections reflect public service differences, not clinical outcomes or firsthand treatment testing.
Ro is relevant when insurance coordination is a central need; its $149 recurring monthly care fee excludes medication. Hers is worth examining when app-centered follow-up is appealing, but its $149 ongoing care membership excludes medication and the complete treatment quote is not established here. Compare how each service handles an unfavorable coverage decision, what care fees remain payable and who owns the next step with the pharmacy.
Mochi lists approved and compounded products. That breadth can support a clinician discussion, but it also means a single advertised medication floor cannot price every treatment route. CoreAge’s narrower compounded semaglutide offer advertises no separate membership; its $79 and $99 displays remain unresolved. Neither breadth nor a low starting figure establishes a better complete offer.
Ask how follow-up, refill review and prescription changes are arranged. A provider that fits your first order may be less useful if the renewal bill or clinician contact is unclear. Keep two options on your shortlist until both identify the exact product, ongoing total and cancellation cutoff. Compounded drugs are not FDA-approved.
We use public information, have not enrolled as patients and do not measure clinical quality or support speed. Individual eligibility, state access, prescription and current terms must be confirmed directly.
Compounded drugs are not FDA-approved. This comparison is not a treatment recommendation. See our commercial disclosure and comparison method.